Aantal gebruikers 2020-2024 voor ATC-subgroep A10B : Bloedglucoseverlagende middelen excl. insulines
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A10BA Biguaniden | 659.610 | 666.830 | 672.480 | 681.760 | 691.070 |
| A10BB Sulfonylureumderivaten | 311.120 | 320.220 | 325.030 | 328.940 | 333.430 |
| A10BD Combinaties van bloedglucoseverlagende middelen | 10.709 | 10.505 | 10.225 | 9.582 | 8.938 |
| A10BF Alfa-glucosidaseremmers | 901 | 780 | 782 | 429 | 191 |
| A10BG Thiazolidinedionen | 2.673 | 2.378 | 2.049 | 1.808 | 1.610 |
| A10BH Dipeptidylpeptidase-4-remmers | 46.883 | 48.884 | 47.843 | 45.857 | 43.472 |
| A10BJ Glucagonachtig peptide-1-agonisten (glp-1-agonisten) | 39.511 | 54.928 | 82.605 | 109.390 | 140.280 |
| A10BK Natriumglucose-cotransporter-2-remmers (sglt-2-remmers) | 19.946 | 39.715 | 113.280 | 179.950 | 249.540 |
| A10BX Overige bloedglucoseverlagende middelen excl. insulines | 703 | 660 | 612 | 564 | 2.506 |